111 related articles for article (PubMed ID: 11715084)
1. Immunohistochemical visualization of newly formed quinolinate in the normal and excitotoxically lesioned rat striatum.
Lehrmann E; Molinari A; Speciale C; Schwarcz R
Exp Brain Res; 2001 Dec; 141(3):389-97. PubMed ID: 11715084
[TBL] [Abstract][Full Text] [Related]
2. 4-Chloro-3-hydroxyanthranilate inhibits quinolinate production in the rat hippocampus in vivo.
Walsh JL; Wu HQ; Ungerstedt U; Schwarcz R
Brain Res Bull; 1994; 33(5):513-6. PubMed ID: 8186995
[TBL] [Abstract][Full Text] [Related]
3. In situ produced 7-chlorokynurenate provides protection against quinolinate- and malonate-induced neurotoxicity in the rat striatum.
Guidetti P; Wu HQ; Schwarcz R
Exp Neurol; 2000 May; 163(1):123-30. PubMed ID: 10785450
[TBL] [Abstract][Full Text] [Related]
4. Thalidomide inhibition of vascular remodeling and inflammatory reactivity in the quinolinic acid-injected rat striatum.
Ryu JK; Jantaratnotai N; McLarnon JG
Neuroscience; 2009 Oct; 163(2):601-8. PubMed ID: 19591904
[TBL] [Abstract][Full Text] [Related]
5. Production of extracellular quinolinic acid in the striatum studied by microdialysis in unanesthetized rats.
Speciale C; Ungerstedt U; Schwarcz R
Neurosci Lett; 1989 Oct; 104(3):345-50. PubMed ID: 2530475
[TBL] [Abstract][Full Text] [Related]
6. Peripheral benzodiazepine receptor ligand PK11195 reduces microglial activation and neuronal death in quinolinic acid-injected rat striatum.
Ryu JK; Choi HB; McLarnon JG
Neurobiol Dis; 2005 Nov; 20(2):550-61. PubMed ID: 15916899
[TBL] [Abstract][Full Text] [Related]
7. Selenium reduces the proapoptotic signaling associated to NF-kappaB pathway and stimulates glutathione peroxidase activity during excitotoxic damage produced by quinolinate in rat corpus striatum.
Santamaría A; Vázquez-Román B; La Cruz VP; González-Cortés C; Trejo-Solís MC; Galván-Arzate S; Jara-Prado A; Guevara-Fonseca J; Ali SF
Synapse; 2005 Dec; 58(4):258-66. PubMed ID: 16206188
[TBL] [Abstract][Full Text] [Related]
8. On the production and disposition of quinolinic acid in rat brain and liver slices.
Speciale C; Schwarcz R
J Neurochem; 1993 Jan; 60(1):212-8. PubMed ID: 8417142
[TBL] [Abstract][Full Text] [Related]
9. NAD(P)H oxidase contributes to neurotoxicity in an excitotoxic/prooxidant model of Huntington's disease in rats: protective role of apocynin.
Maldonado PD; Molina-Jijón E; Villeda-Hernández J; Galván-Arzate S; Santamaría A; Pedraza-Chaverrí J
J Neurosci Res; 2010 Feb; 88(3):620-9. PubMed ID: 19795371
[TBL] [Abstract][Full Text] [Related]
10. Elevation of Met-enkephalin-like immunoreactivity in the rat striatum and globus pallidus following the focal injection of excitotoxins.
Ruzicka BB; Jhamandas K
Brain Res; 1990 Dec; 536(1-2):227-39. PubMed ID: 2150770
[TBL] [Abstract][Full Text] [Related]
11. 4-chloro-3-hydroxyanthranilate reduces local quinolinic acid synthesis, improves functional recovery, and preserves white matter after spinal cord injury.
Yates JR; Heyes MP; Blight AR
J Neurotrauma; 2006 Jun; 23(6):866-81. PubMed ID: 16774472
[TBL] [Abstract][Full Text] [Related]
12. Quinolinic acid neurotoxicity: in vivo increased copper and manganese content in rat corpus striatum after quinolinate intrastriatal injection.
Santamaría A; Ríos C; Pérez P; Flores A; Galván-Arzate S; Osorio-Rico L; Solís F
Toxicol Lett; 1996 Oct; 87(2-3):113-9. PubMed ID: 8914619
[TBL] [Abstract][Full Text] [Related]
13. Quinolinic acid accumulation and functional deficits following experimental spinal cord injury.
Blight AR; Cohen TI; Saito K; Heyes MP
Brain; 1995 Jun; 118 ( Pt 3)():735-52. PubMed ID: 7600090
[TBL] [Abstract][Full Text] [Related]
14. Changes in transition metal contents in rat brain regions after in vivo quinolinate intrastriatal administration.
Pérez P; Flores A; Santamaría A; Ríos C; Galván-Arzate S
Arch Med Res; 1996; 27(4):449-52. PubMed ID: 8987176
[TBL] [Abstract][Full Text] [Related]
15. Acute and chronic changes in kynurenate formation following an intrastriatal quinolinate injection in rats.
Ceresoli-Borroni G; Guidetti P; Schwarcz R
J Neural Transm (Vienna); 1999; 106(3-4):229-42. PubMed ID: 10392532
[TBL] [Abstract][Full Text] [Related]
16. Time- and dose-dependent 45Ca2+ accumulation in rat striatum and substantia nigra after an intrastriatal injection of quinolinic acid.
Gramsbergen JB; van der Sluijs-Gelling AJ
Exp Neurol; 1993 Jun; 121(2):261-9. PubMed ID: 8339777
[TBL] [Abstract][Full Text] [Related]
17. The kynurenine pathway and neurologic disease. Therapeutic strategies.
Heyes MP
Adv Exp Med Biol; 1996; 398():125-9. PubMed ID: 8906254
[TBL] [Abstract][Full Text] [Related]
18. 3-Hydroxykynurenine potentiates quinolinate but not NMDA toxicity in the rat striatum.
Guidetti P; Schwarcz R
Eur J Neurosci; 1999 Nov; 11(11):3857-63. PubMed ID: 10583474
[TBL] [Abstract][Full Text] [Related]
19. 4-Chloro-3-hydroxyanthranilate, 6-chlorotryptophan and norharmane attenuate quinolinic acid formation by interferon-gamma-stimulated monocytes (THP-1 cells).
Saito K; Chen CY; Masana M; Crowley JS; Markey SP; Heyes MP
Biochem J; 1993 Apr; 291 ( Pt 1)(Pt 1):11-4. PubMed ID: 8471029
[TBL] [Abstract][Full Text] [Related]
20. Metabolism of [5-(3)H]kynurenine in the developing rat brain in vivo: effect of intrastriatal ibotenate injections.
Ceresoli G; Guidetti P; Schwarcz R
Brain Res Dev Brain Res; 1997 May; 100(1):73-81. PubMed ID: 9174248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
